The majority of humangastrointestinal mesenchymal tumors are gastrointestinal stromal tumors (GISTs). Recent reports have shownthe existence of gain-of-function mutations in the juxta-membrane domain of receptor tyrosine kinase (KIT) in GISTs. We present a 77-year-old womanwith GIST diagnosed by positive immunostaining of cluster designation (CD) 34 and KIT. This case had a novel mutation at codon 576 located in the juxta-membrane domain of KIT. Our results indicate the importance of mutations in this KIT region and suggest the possibility of the existence of other types of mutations in this region in GISTs. (Internal Medicine 40: 301-303, 2001) 
Introduction
A large number of interstitial tumors found in the human gastrointestinal tract are designated as gastrointestinal stromal cell tumors (GISTs), since they exhibit typical features different from either smoothmuscle cells or Schwanncells (1) . Positive immunostaining of cluster designation (CD) 34 and receptor tyrosine kinase (KIT) indicates that most GISTs are derived from interstitial Cajal cells (2) (3) (4) . KIT, a receptor tyrosine kinase (5, 6) , and its ligand stem cell factor play a crucial role in the development of interstitial cells of Cajal (7) (8) . To date, gain-of-function mutations in KIT have been reported in these tumors (4, 9) . Interestingly, all of these mutations were confined within the KIT juxta-membrane domain. Thus, mutations in this region seem to be associated with the tumorigenesis of GISTs. In the present report, we investigated whether or not any mutation existed in this region in a case of GIST.
Case Report A77-year-old Japanese womancame to us suffering from a gastric tumor. A 6.0x4.5 cm submucosal tumor was detected at the upper body greater curvature of the stomach. Under the diagnosis of a gastric sarcoma, the tumor was surgically resected. Morphologically, the tumor was located in the submucosa of the stomach and protruded from the serosa membrane. The section was myxoidand contained a cystic region with a small amount of blood. Histologically, the tumor was comprised of spindle-shaped cells with plump nuclei. Cell density was high and the mitotic index was less than 5 in consecutive 50 highpower fields. The degree of dysplasia was mild to moderate. Immunohistochemically, the tumor was negative for desmin, muscle specific actin, smooth muscle actin, S I00, and vimentin staining. However, it was strongly positive for KIT (Fig. 1A ) and CD34 staining (Fig. IB) . The genomic sequence of the juxta-membrane region and carboxyl terminus of the KIT protooncogene was determined using DNAextracted from the tumor portion of the paraffin-embedded section and peripheral WBC.These regions were amplified by a nested polymerase chain reaction and subcloned followed by sequencing using a dideoxy chain termination method. Nomutation was seen in any codon between 550 to 560. However, a point mutation (C to T) at codon 576 which converts prolin to leucin was detected in 4 of the 8 clones investigated (Fig. 2) . No mutation was seen in the DNA from WBC.
Discussion
In humanGISTs, all the gain-of-function mutations were first thought to be confined within the ll amino acids (codon 550 to codon 560) (4), and later a deletion mutation at codon 578 was reported as a novel gain-of-function mutation (9) . Although a mutation in the KIT tyrosine kinase domain has been shown to be another gain-of-function mutation, it has only been seen in the mast cell neoplasm (10) (11) (12) . These findings indicate that mutations in the KIT juxta-membrane domain has a crucial role with GIST tumorigenesis. The case presented in this report was diagnosed as a GIST from the positive staining of CD34and KIT. However, no mutation was detected within the 1 1 amino acids or at codon 578, which have been reported previously (4, 9) . Interestingly, we found a novel mutation at codon 576 in the KIT proto-oncogene. This novel mutation was also located in the juxta-membrane domain like other mutations. Whether or not this is a gain-offunction mutation is not clear. However, half of the genomic DNAclones from the tumor and all the DNAfrom the WBC had no mutation in this region. Together with the fact that all mutations in human GISTs have been confined within this region, our findings suggest the possibility that this point mutation is also a KIT gain-of-function mutation. Recently, a germline mutation of the KIT proto-oncogene has been shown in some of the membersof familial GISTsby detection of KIT mutation in DNAfrom WBC (13) . However, the present case had no such family history of gastrointestinal tumors nor the GIST with a Novel Mutation in KIT mutation in genomic DNAfrom WBC. Although further investigation is necessary to reconcile whether this novel mutation is a gain-of-function mutation or not, our results indicate the importance of mutations in this KIT region and suggest the possibility of the existence of other types of mutations in this region in GISTs.
